Medicine:SCTV01C
From HandWiki
Short description: Vaccine candidate against COVID-19
| Vaccine description | |
|---|---|
| Target disease | SARS-CoV-2 |
| Type | Protein subunit |
| Clinical data | |
| Routes of administration | Intramuscular |
SCTV01C is a COVID-19 vaccine candidate developed by Sinocelltech.[1][2][3]
References
- ↑ "The Safety and Efficacy of SCTV01C in Population Aged ≥18 Years Previously Vaccinated With Inactivated COVID-19 Vaccine.Healthy Population Aged ≥18 Years Previously Vaccinated With Adenovirus Vectored or mRNA COVID-19 Vaccine.". United States National Library of Medicine. 14 September 2021. https://clinicaltrials.gov/ct2/show/NCT05043311.
- ↑ "The Safety and Efficacy of SCTV01C in Population Aged ≥18 Years Previously Vaccinated With Inactivated COVID-19 Vaccine.Healthy Population Aged ≥18 Years Previously Vaccinated With Inactivated COVID-19 Vaccine.". United States National Library of Medicine. 14 September 2021. https://clinicaltrials.gov/ct2/show/NCT05043285.
- ↑ "Safety, Tolerability and Immunogenicity of SCTV01C in Healthy Population Aged ≥18 Years Previously Unvaccinated". United States National Library of Medicine. 8 December 2021. https://clinicaltrials.gov/ct2/show/NCT05148091.
 |
